Insider Trading & Ownership of DAVID MOTT

Location: Baltimore, MD
Summary: The estimated net worth of DAVID MOTT is at least $14,945,764 dollars as of 06 Jan 2026. DAVID MOTT is the Director of ARDELYX, INC. and owns shares of ARDELYX, INC. (ARDX) stock worth about $10.75M. DAVID MOTT is the Director of IMARA Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $3.47M. DAVID MOTT is the Director of NOVAVAX INC and owns shares of NOVAVAX INC (NVAX) stock worth about $703.6K. DAVID MOTT is the Director of Epizyme, Inc. and owns shares of Epizyme, Inc. stock worth about $23K.
Signature: /s/ David Mott
All Insider Reports: All Insider Reports

Notify me when DAVID MOTT files a new Insider Trading report.

Ownership of DAVID MOTT

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
ARDX	ARDELYX, INC.	Director	$10,749,897	+$4,784,606	+80%	18 Jun 2025
ELVN, IMRA	Enliven Therapeutics, Inc.	Director	$3,469,305			02 Jun 2022
NVAX	NOVAVAX INC	Director	$703,599			20 Jun 2025
EPZM	Epizyme, Inc.	Director	$22,963			12 Aug 2022
MRSN	Mersana Therapeutics, Inc.	Director	$0			06 Jan 2026
ADAP	Adaptimmune Therapeutics PLC	Director				01 Jul 2024

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.